{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:58:45Z","timestamp":1789570725983,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10792-018-0934-y","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T08:17:05Z","timestamp":1525853825000},"page":"1255-1262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Functional and morphological assessment of ocular structures and follow-up of patients with early-stage Parkinson\u2019s disease"],"prefix":"10.1007","volume":"39","author":[{"given":"Samir","family":"Hasanov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Demirkilinc Biler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Acarer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezmi","family":"Akk\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafer","family":"Colakoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onder","family":"Uretmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,9]]},"reference":[{"key":"934_CR1","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awp068","volume":"132","author":"NK Archibald","year":"2009","unstructured":"Archibald NK, Clarke MP, Mosimann UP et al (2009) The retina in Parkinson\u2019s disease. Brain 132:1128\u20131145","journal-title":"Brain"},{"key":"934_CR2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3928\/0191-3913-19960501-04","volume":"33","author":"MX Repka","year":"1996","unstructured":"Repka MX, Claro MC, Loupe DN et al (1996) Ocular motility in Parkinson\u2019s disease. J Pediatr Ophthalmol Strabismus 33:144\u2013147","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"934_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/jnnp.70.6.727","volume":"70","author":"J Barnes","year":"2001","unstructured":"Barnes J, David AS (2001) Visual hallucinations in Parkinson\u2019s disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 70:727\u2013733","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"934_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/01.WNL.0000103444.45882.D8","volume":"62","author":"V Biousse","year":"2004","unstructured":"Biousse V, Skibell BC, Watts RL et al (2004) Ophthalmologic features of Parkinson\u2019s disease [see comment]. Neurology 62:177\u2013180","journal-title":"Neurology"},{"key":"934_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4274\/tjo.46547","volume":"45","author":"ES Sari","year":"2015","unstructured":"Sari ES, Koc R, Yazici A, Sahin G, Cakmak H, Kocaturk T, Ermis SS (2015) Tear osmolarity, break-up time and Schirmer\u2019s scores in Parkinson\u2019s disease. Turk J Ophthalmol 45:142\u2013145","journal-title":"Turk J Ophthalmol"},{"key":"934_CR6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/archneur.63.5.713","volume":"63","author":"CG Goetz","year":"2006","unstructured":"Goetz CG, Fan W, Leurgans S et al (2006) The malignant course of \u2018benign hallucinations\u2019 in Parkinson disease. Arch Neurol 63:713\u2013716","journal-title":"Arch Neurol"},{"key":"934_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/bjo.84.5.499","volume":"84","author":"K Manuchehri","year":"2000","unstructured":"Manuchehri K, Goodman S, Siviter L et al (2000) A controlled study of vigabatrin and visual abnormalities. Br J Ophthalmol 84:499\u2013505","journal-title":"Br J Ophthalmol"},{"key":"934_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1017\/S0317167100004443","volume":"32","author":"MC Moreno","year":"2005","unstructured":"Moreno MC, Giagante B, Saidon P et al (2005) Visual defects associated \u00fcith vigabatrin: a study of epileptic Argentine patients. Can J Neurol Sci 32:459\u2013464","journal-title":"Can J Neurol Sci"},{"key":"934_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM Lau De","year":"2006","unstructured":"De Lau LM, Breteler MM (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5:525\u2013535","journal-title":"Lancet Neurol"},{"key":"934_CR10","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1212\/WNL.45.12.2143","volume":"45","author":"MC Rijk De","year":"1995","unstructured":"De Rijk MC, Breteler MM, Graveland GA et al (1995) Prevalence of Parkinson\u2019s disease in the elderly: the Rotterdam study. Neurology 45:2143\u20132146","journal-title":"Neurology"},{"key":"934_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/eye.2013.4","volume":"27","author":"M Satue","year":"2013","unstructured":"Satue M, Garcia-Martin E, Fuertes I et al (2013) Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson\u2019s disease patients. Eye (Lond) 27:507\u2013514","journal-title":"Eye (Lond)"},{"key":"934_CR12","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1002\/mds.23891","volume":"26","author":"NK Archibald","year":"2011","unstructured":"Archibald NK, Clarke MP, Mosimann UP et al (2011) Visual symptoms in Parkinson\u2019s disease and Parkinson\u2019s disease dementia. Mov Disord 26:2387\u20132395","journal-title":"Mov Disord"},{"key":"934_CR13","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.12659\/MSM.890861","volume":"20","author":"B Nowacka","year":"2014","unstructured":"Nowacka B, Lubinski W, Honczarenko K et al (2014) Ophthalmological features of Parkinson disease. Med Sci Monit 20:2243\u20132249","journal-title":"Med Sci Monit"},{"key":"934_CR14","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/aos.12764","volume":"93","author":"B Stemplewitz","year":"2015","unstructured":"Stemplewitz B, Keser\u00fc M, Bittersohl D et al (2015) Scanning laser polarimetry and sprctral domain optical coherence tomography for the detection of retinal changes in Parkinson\u2019s disease. Acta Ophthalmol 93:672\u2013677","journal-title":"Acta Ophthalmol"},{"key":"934_CR15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/WNO.0000000000000203","volume":"35","author":"ES Sari","year":"2015","unstructured":"Sari ES, Koc R, Yazici A et al (2015) Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association wiht disease severity and duration. J Neuroophthalmol 35:117\u2013121","journal-title":"J Neuroophthalmol"},{"key":"934_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/WNO.0000000000000240","volume":"35","author":"M Kaur","year":"2015","unstructured":"Kaur M, Saxena R, Singh D et al (2015) Correlation between structural and functional retinal changes in Parkinson disease. J Neuroophthalmol 35:254\u2013258","journal-title":"J Neuroophthalmol"},{"key":"934_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.mrfmmm.2008.11.002","volume":"66","author":"SC Sacca","year":"2009","unstructured":"Sacca SC, Bolognesi C, Battistella A et al (2009) Gene-environment interactions in ocular diseases. Mutat Res 66:98\u2013117","journal-title":"Mutat Res"},{"key":"934_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2415-12-54","volume":"12","author":"EE Tsironi","year":"2012","unstructured":"Tsironi EE, Dastiridou A, Katsanos A et al (2012) Perimetric and retinal nerve fiber layer findings in patients with Parkinson\u2019s disease. BMC Ophthalmol 12:54","journal-title":"BMC Ophthalmol"},{"key":"934_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0002-9394(01)01196-5","volume":"133","author":"AU Bayer","year":"2002","unstructured":"Bayer AU, Keller ON, Ferrari F et al (2002) Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer\u2019s disease and Parkinson\u2019s disease. Am J Ophthalmol 133:135\u2013137","journal-title":"Am J Ophthalmol"},{"key":"934_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.parkreldis.2007.07.018","volume":"14","author":"O Yenice","year":"2008","unstructured":"Yenice O, Onal S, Midi I et al (2008) Visual field analysis in patients with Parkinson\u2019s disease. Parkinsonism Relat Disord 14:193\u2013198","journal-title":"Parkinsonism Relat Disord"},{"key":"934_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/00055735-199704000-00006","volume":"8","author":"SJ McKinnon","year":"1997","unstructured":"McKinnon SJ (1997) Glaucoma, apoptosis, and neuroprotection. Curr Opin Ophthalmol 8:28\u201337","journal-title":"Curr Opin Ophthalmol"},{"key":"934_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1388-2457(99)00223-0","volume":"111","author":"T Langheinrich","year":"2000","unstructured":"Langheinrich T, Tebartz van Elst L, Lagreze WA et al (2000) Visual contrast response functions in Parkinson\u2019s disease: evidence from electroretinograms, visually evoked potentials and psychophysics. Clin Neurophysiol 111:66\u201374","journal-title":"Clin Neurophysiol"},{"key":"934_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0022-510X(99)00204-X","volume":"172","author":"V Pieri","year":"2000","unstructured":"Pieri V, Diederich NJ, Raman R et al (2000) Decreased colour discrimination and contrast sensitivity in Parkinson\u2019s disease. J Neurol Sci 172:7\u201311","journal-title":"J Neurol Sci"},{"issue":"Suppl 1","key":"934_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.parkreldis.2015.09.015","volume":"22","author":"S Miri","year":"2016","unstructured":"Miri S, Glazman S, Mylin L et al (2016) A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson\u2019s disease. Parkinsonism Relat Disord 22(Suppl 1):134\u2013137","journal-title":"Parkinsonism Relat Disord"},{"key":"934_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1001\/archneur.1982.00510170026007","volume":"39","author":"MJ Kupersmith","year":"1982","unstructured":"Kupersmith MJ, Shakin E, Siegel IM et al (1982) Visual system abnormalities in patients with Parkinson\u2019s disease. Arch Neurol 39:284\u2013286","journal-title":"Arch Neurol"},{"key":"934_CR26","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1212\/WNL.41.8.1200","volume":"41","author":"JT Hutton","year":"1991","unstructured":"Hutton JT, Morris JL, Elias JW et al (1991) Spatial contrast sensitivity is reduced bilaterally in Parkinson\u2019s disease. Neurology 41:1200\u20131202","journal-title":"Neurology"},{"key":"934_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s007020050007","volume":"107","author":"T Buttner","year":"2000","unstructured":"Buttner T, Muller T, Kuhn W (2000) Effects of apomorphine on visual functions in Parkinson\u2019s disease. J Neural Transm 107:87\u201394","journal-title":"J Neural Transm"},{"key":"934_CR28","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1016\/S0042-6989(97)00398-2","volume":"38","author":"J Birch","year":"1998","unstructured":"Birch J, Kolle RU, Kunkel M et al (1998) Acquired colour deficiency in patients with Parkinson\u2019s disease. Vis Res 38:3421\u20133426","journal-title":"Vis Res"},{"key":"934_CR29","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1468-1331.2010.03206.x","volume":"18","author":"YS Oh","year":"2011","unstructured":"Oh YS, Kim JS, Chunq SW et al (2011) Color vision in Parkinson`s disease and essential tremor. Eur J Neurol 18:577\u2013583","journal-title":"Eur J Neurol"},{"key":"934_CR30","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1007\/BF01946404","volume":"42","author":"TA Reader","year":"1986","unstructured":"Reader TA, Quesney LF (1986) Dopamine in the visual cortex of the cat. Experientia 42:1242\u20131244","journal-title":"Experientia"},{"key":"934_CR31","first-page":"1","volume-title":"Vision and the brain: the organization of the central visual system","author":"JE Dowling","year":"1990","unstructured":"Dowling JE (1990) Functional and pharmacological organization of the retina: dopamine, interplexiform cells, and neuromodulation. In: Cohen B, Bodis-Wollner I (eds) Vision and the brain: the organization of the central visual system. Raven Press, New York, pp 1\u201318"},{"key":"934_CR32","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1167\/iovs.03-0815","volume":"45","author":"M Castelo-Branco","year":"2004","unstructured":"Castelo-Branco M, Faria P, Forjaz V et al (2004) Simultaneous comparison of relative damage to chromatic pathways in ocular hypertension and glaucoma: correlation with clinical measures. Investig Ophthalmol Vis Sci 45:499\u2013505","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"934_CR33","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1001\/archopht.123.7.944","volume":"123","author":"SH Campos","year":"2005","unstructured":"Campos SH, Forjaz V, Kozak LR et al (2005) Quantitative phenotyping of chromati dysfunction in best macular dystrophy. Arch Ophthalmol 123:944\u2013949","journal-title":"Arch Ophthalmol"},{"key":"934_CR34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/0168-5597(96)95700-7","volume":"100","author":"TH Buttner","year":"1996","unstructured":"Buttner TH, Kuhn W, M\u00fcller TH et al (1996) Chromatic and achromatic visual evoked potentials in Parkinson\u2019s disease. Electroenceph Clin Neurophysiol 100:443\u2013447","journal-title":"Electroenceph Clin Neurophysiol"},{"key":"934_CR35","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1212\/WNL.35.4.610","volume":"35","author":"DS Dinner","year":"1985","unstructured":"Dinner DS, L\u00fcders H, Hanson M et al (1985) Pattern evoked potentials (PEPS) in Parkinson\u2019s disease. Neurology 35:610\u2013613","journal-title":"Neurology"},{"key":"934_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0168-5597(94)90057-4","volume":"92","author":"L Barbato","year":"1994","unstructured":"Barbato L, Rinalduzzi S, Laurenti M et al (1994) Color VEPs in Parkinson\u2019s disease. Electroenceph Clin Neurophysiol 92:169\u2013172","journal-title":"Electroenceph Clin Neurophysiol"},{"key":"934_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10633-007-9091-8","volume":"1116","author":"O Altintas","year":"2008","unstructured":"Altintas O, Iseri P, Ozkan B et al (2008) Correlation between retinal morphological and functional findings and clinical severity in Parkinson\u2019s disease. Doc Ophthalmol 1116:137\u2013146","journal-title":"Doc Ophthalmol"},{"key":"934_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5301\/EJO.2010.1318","volume":"21","author":"MM Moschos","year":"2010","unstructured":"Moschos MM, Tagaris G, Markopoulos I et al (2010) Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol 21:24\u201329","journal-title":"Eur J Ophthalmol"},{"key":"934_CR39","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.ophtha.2012.05.003","volume":"119","author":"E Garcia-Martin","year":"2012","unstructured":"Garcia-Martin E, Satue M, Fuertes I et al (2012) Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson\u2019s disease. Ophthalmology 119:2161\u20132167","journal-title":"Ophthalmology"},{"key":"934_CR40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/WNO.0b013e3182701745","volume":"33","author":"S Kirbas","year":"2013","unstructured":"Kirbas S, Turkyilmaz K, Tufekci A et al (2013) Retinal nerve fiber layer thickness in Parkinson disease. J Neuroophthalmol 33:62\u201365","journal-title":"J Neuroophthalmol"},{"key":"934_CR41","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1167\/iovs.13-13062","volume":"55","author":"E Garcia-Martin","year":"2014","unstructured":"Garcia-Martin E, Rodrigues-Mena D, Satue M et al (2014) Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity. Investig Ophthalmol Vis Sci 55:696\u2013705","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"934_CR42","doi-asserted-by":"publisher","first-page":"e85718","DOI":"10.1371\/journal.pone.0085718","volume":"9","author":"JG Yu","year":"2014","unstructured":"Yu JG, Feng YF, Xiang Y et al (2014) Retinal nerve fiber layer thickness changes in Parkinson disease: a meta- analysis. PLoS ONE 9(1):e85718","journal-title":"PLoS ONE"},{"key":"934_CR43","first-page":"1427","volume":"4","author":"GD Aaker","year":"2010","unstructured":"Aaker GD, Myung JS, Ehrlich JR et al (2010) Detection of retinal changes in Parkinson\u2019s disease with spectral-domain optical coherence tomography. Clin Ophthalmol 4:1427\u20131432","journal-title":"Clin Ophthalmol"},{"key":"934_CR44","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.parkreldis.2011.03.004","volume":"17","author":"NK Archibald","year":"2011","unstructured":"Archibald NK, Clarke MP, Mosimann UP et al (2011) Retinal thickness in Parkinson\u2019s disease. Parkinsonism Relat Disord 17:431\u2013436","journal-title":"Parkinsonism Relat Disord"},{"key":"934_CR45","doi-asserted-by":"publisher","first-page":"e34891","DOI":"10.1371\/journal.pone.0034891","volume":"7","author":"P Albrecht","year":"2012","unstructured":"Albrecht P, Muller AK, Sudmeyer M et al (2012) Optical coherence tomography in parkinsonian syndromes. PLoS ONE 7:e34891","journal-title":"PLoS ONE"},{"key":"934_CR46","doi-asserted-by":"publisher","first-page":"728457","DOI":"10.1155\/2012\/728457","volume":"2012","author":"EM Shrier","year":"2012","unstructured":"Shrier EM, Adam CR, Spund B et al (2012) Interocular asymmetry of foveal thickness in Parkinson disease. J Ophthalmol 2012:728457","journal-title":"J Ophthalmol"},{"key":"934_CR47","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/archophthalmol.2009.106","volume":"127","author":"M Hajee","year":"2009","unstructured":"Hajee M, March W, Lazzaro D et al (2009) Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 127:737\u2013741","journal-title":"Arch Ophthalmol"},{"key":"934_CR48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/WNO.0b013e31828c4e1a","volume":"33","author":"C Adam","year":"2013","unstructured":"Adam C, Shrier E, Bodis-Wollner I et al (2013) Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease. J Neuroophthalmol 33:137\u2013142","journal-title":"J Neuroophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-018-0934-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-018-0934-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-018-0934-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T22:26:42Z","timestamp":1661207202000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-018-0934-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,9]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["934"],"URL":"https:\/\/doi.org\/10.1007\/s10792-018-0934-y","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,9]]},"assertion":[{"value":"6 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from the subjects, and the study was conducted according to the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}